Update

ACT-AD, Critical Path Institute and the Alzheimer’s Association Host Working Session

ACT-AD together with the Critical Path Institute and the Alzheimer’s Association host a 3-day working session with leaders from the U.S. Department of Health and Human Services, the U.S. Food and Drug Administration, the National Institutes of Health (NIH), the academic research community, the pharmaceutical industry, private philanthropy, and patient advocacy groups to address next steps in combination therapy development for Alzheimer’s Disease.
View Agenda
View Participant List
View Transcript
Read Alzheimer Research Forum Article

Categories:
Uncategorized